Vivos (RDGL) Income from Continuing Operations (2010 - 2025)
Vivos' (RDGL) quarterly Income from Continuing Operations came in at 1078514.0 in Q4 2025, down 5.41% year-on-year from 1140165.21 in Q4 2024, and down 112.6% quarter-over-quarter from 507294.0 in Q3 2025.
Vivos (RDGL) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Vivos has disclosed Income from Continuing Operations across 16 years of filings, most recently posting 1078514.0 for Q4 2025.
- Income from Continuing Operations for Q4 2025 came in at 1078514.0, down 5.41% year-over-year; the trailing twelve-month figure through Dec 2025 was 3066017.0 (down 5.35% YoY), and the FY2025 annual result was 3066017.0, down 5.35% from the prior year.
- Income from Continuing Operations came in at 1078514.0 for Q4 2025 at Vivos, down from 507294.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 178230.0 in Q4 2021 to a low of 1860187.0 in Q2 2021.
- The 5-year median for Income from Continuing Operations is 683797.5 (2022), against an average of 693457.25.
- Across the five-year window, Income from Continuing Operations tumbled 1069.29% in 2021 and jumped 64.52% in 2023, its largest moves.
- Vivos' Income from Continuing Operations stood at 178230.0 in 2021, then tumbled by 295.92% to 705653.0 in 2022, then sank by 52.51% to 1076219.0 in 2023, then grew by 4.93% to 1023188.0 in 2024, then retreated by 5.41% to 1078514.0 in 2025.
- The last three Income from Continuing Operations figures came in at 1078514.0 (Q4 2025), 507294.0 (Q3 2025), and 645513.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Vivos | - | - | -3,105.00 | -1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | -507,294.00 |
| Jun 30, 2025 | -645,513.00 |
| Mar 31, 2025 | -834,696.00 |
| Dec 31, 2024 | -1.02 Mn |
| Sep 30, 2024 | -825,263.00 |
| Jun 30, 2024 | -503,458.00 |
| Mar 31, 2024 | -558,539.00 |
| Dec 31, 2023 | -1.08 Mn |
| Sep 30, 2023 | -667,690.00 |
| Jun 30, 2023 | -902,526.00 |
| Mar 31, 2023 | -248,318.00 |
| Dec 31, 2022 | -705,653.00 |
| Sep 30, 2022 | -277,065.00 |
| Jun 30, 2022 | -787,538.00 |
| Mar 31, 2022 | -699,905.00 |
| Dec 31, 2021 | -178,230.00 |
| Sep 30, 2021 | -201,160.00 |
| Jun 30, 2021 | -1.86 Mn |
| Mar 31, 2021 | -288,189.00 |